Sarepta Therapeutics: a biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases. Our primary focus is on rapidly advancing Duchenne muscular dystrophy (DMD) therapies that are designed to treat the underlying cause of the disease.

Contact Sarepta therapeutics
617.274.4000
info@sarepta.com
media@sarepta.com
Visit Website